Nivolumab-induced severe pancytopenia in a patient with lung adenocarcinoma-Reference-Cited by-同舟云学术

Nivolumab-induced severe pancytopenia in a patient with lung adenocarcinoma

Published:2018-05 Issue: Volume:119 Page:21-24
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Tokumo Kentaro,Masuda Takeshi,Miyama Takahiko,Miura Shinichiro,Yamaguchi Kakuhiro,Sakamoto Shinjiro,Horimasu Yasushi,Nakashima Taku,Miyamoto Shintaro,Yoshida Takashi,Iwamoto Hiroshi,Fujitaka Kazunori,Hamada Hironobu,Hattori Noboru

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference10 articles.

1. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N. Engl. J. Med.,2015

2. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N. Engl. J. Med,2015

3. Severe agranulocytosis in a patient with metastatic non-small-cell lung cancer treated with nivolumab;Tabchi;Lung Cancer,2016

4. Idiopathic thrombocytopenic purpura induced by nivolumab in a metastatic melanoma patient with elevated PD-1 expression on B cells;Kanameishi;Ann. Oncol.,2016

5. Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus: a case report;Inadomi;Medicine (Baltimore),2016

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of immune checkpoint inhibitors in the development and treatment of infectious processes;Journal of Clinical Practice;2024-04-17

2. Exploring Immune-Related Adverse Events: A Case of Febrile Neutropenia in a Melanoma Patient Receiving Immunotherapy;Case Reports in Oncology;2024-03-04

3. Case Report: Life-threatening pancytopenia with tislelizumab followed by cerebral infarction in a patient with lung adenocarcinoma;Frontiers in Immunology;2023-07-25

4. Case report: A rare case of acute hemolysis in advanced rectal cancer after XELOX and nivolumab treatment: analysis of drug-dependent antibodies;Frontiers in Medicine;2023-05-25

5. Antithymocyte globulin for aplastic anemia secondary to pembrolizumab: a case report and review of literature;Immunotherapy;2023-04